Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
about
Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst FacetHigher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastomaPD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.Future perspectives for personalized immunotherapy in renal cell carcinoma.Decreased expression of EphA5 is associated with Fuhrman nuclear grade and pathological tumour stage in ccRCC.PD-1/PD-L1 blockade in renal cell cancer.The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review.The Expression of VHL (Von Hippel-Lindau) After Traumatic Spinal Cord Injury and Its Role in Neuronal Apoptosis.GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.Novel concepts of antiangiogenic therapies in metastatic renal cell cancer.PD-L1 Overexpression During Endotoxin Tolerance Impairs the Adaptive Immune Response in Septic Patients via HIF1α.Cancer stem cells as targets for immunotherapy.CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT.The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200.Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.Immune consequences of anti-angiogenic therapyin renal cell carcinoma.Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression
P2860
Q28079816-644C38BB-95F4-444D-B342-9DEF40003BEBQ37709473-370FD24E-21D7-411C-9EDF-3975BB5213DEQ37715066-499132F1-D602-48D3-A355-B42DD7ADB28EQ38607549-0D537635-2094-41FA-A4C0-2D2F89A59897Q38673583-A5CF84B2-4534-4369-A155-15C9CD754D80Q38831040-D9C71170-B140-4154-8788-DF864363E3D2Q38899769-3179B03B-5761-4E92-B24D-0D26435445A3Q38910154-DB8E6E24-6B71-455A-85F4-0CD71CBB13C1Q39668861-4C0E7AFD-1741-4015-8740-6E48C6636591Q42315418-09665FEA-1A99-46D3-BADF-1451E1C2A9E0Q47144667-2395A0D6-B6FB-457E-BAA1-21550041A4D4Q47755022-5BC824C8-1138-41AA-A440-12DC809957E4Q48278683-F896B5F7-E2B6-454F-A02A-42D33B7CCD31Q52597558-3A13E639-688D-471D-B246-43036922345EQ52722403-34E8B7EC-BCB3-4B9E-AEE6-394154DBD43DQ52726721-735E0D5F-7831-45A4-B520-33A9D550F9E4Q52821559-7352ED49-3999-4DC0-97F6-9DB2E9A446E6Q54981236-36CBBB20-CE1A-4456-9322-7D49CA95037BQ58702903-E684CEBB-E706-4F14-82A8-A71B3999A6BE
P2860
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Renal Cell Carcinoma Programme ...... l-Lindau Gene Mutation Status.
@en
type
label
Renal Cell Carcinoma Programme ...... l-Lindau Gene Mutation Status.
@en
prefLabel
Renal Cell Carcinoma Programme ...... l-Lindau Gene Mutation Status.
@en
P2093
P50
P1433
P1476
Renal Cell Carcinoma Programme ...... l-Lindau Gene Mutation Status.
@en
P2093
Alexander M M Eggermont
Arnaud Mejean
Bassam Janji
David Robert Mole
Fathia Mami-Chouaib
Laurence Albiges
Muhammad Zaeem Noman
Nathalie Rioux-Leclerc
Salem Chouaib
Solenne Florence Kammerer
P304
P356
10.1016/J.EURURO.2015.11.029
P407
P50
P577
2015-12-17T00:00:00Z